Summary of Purpose
To determine whether treatment with nimodipine would prevent or reduce the severity of ischemic neurologic deficits from arterial spasm.Read More →
The following dates are available for this trial. Trial information last updated on 12 April 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Miles Pharmaceuticals.
Prospective, double-blind, randomized, stratified, placebo-controlled trial of 125 patients at 5 centers. Patients stratified by center and treating physician.